Related references
Note: Only part of the references are listed.Hypoxia enhances lipid uptake in macrophages: Role of the scavenger receptors Lox1, SRA, and CD36
Margot Crucet et al.
ATHEROSCLEROSIS (2013)
Foam cells in atherosclerosis
Xiao-Hua Yu et al.
CLINICA CHIMICA ACTA (2013)
Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State
Isabella Savini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors
Erica N. Montano et al.
JOURNAL OF LIPID RESEARCH (2013)
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C
S. Petta et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease
Takashi Himoto et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Sunghee Cho
CURRENT PHARMACEUTICAL DESIGN (2012)
Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes
H. S. Schipper et al.
DIABETOLOGIA (2012)
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
Rossella Liani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population
A. Handberg et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Inflammation, Oxidative Stress, and Obesity
Alba Fernandez-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles
M. J. Alkhatatbeh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
Debby P.Y. Koonen et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
OXIDIZED LOW-DENSITY LIPOPROTEIN AND ANKLE-BRACHIAL PRESSURE INDEX IN PATIENTS WITH CLINICALLY EVIDENT PERIPHERAL ARTERIAL DISEASE
Ruben Miguel Ayzin Rosoky et al.
CLINICS (2010)
Molecular imaging in atherosclerosis
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Plaqueta e leptina em adolescentes com obesidade
Denis Foschini et al.
Jornal de Pediatria (2010)
Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
A. Handberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Nuts and novel biomarkers of cardiovascular disease
Emilio Ros
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Association of Scavenger Receptors in Adipose Tissue With Insulin Resistance in Nondiabetic Humans
Neda Rasouli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36
R. L. SILVERSTEIN
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men
Aase Handberg et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Prevalence of Cardiovascular Risk Factors in Taiwanese Healthcare Workers
Chih-Ming Lin et al.
INDUSTRIAL HEALTH (2009)
CD36 and TLR Interactions in Inflammation and Phagocytosis: Implications for Malaria
Laura K. Erdman et al.
JOURNAL OF IMMUNOLOGY (2009)
CD36: A multi-modal target for acute stroke therapy
Sunghee Cho et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance
Jose-Manuel Fernandez-Real et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Platelet counts and platelet activation markers in obese subjects
Dorit Samocha-Bonet et al.
MEDIATORS OF INFLAMMATION (2008)
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
CD36 and macrophages in atherosclerosis
Sophie Collot-Teixeira et al.
CARDIOVASCULAR RESEARCH (2007)
Prevalence of hypertension and pre-hypertension among adolescents
Karen L. McNiece et al.
JOURNAL OF PEDIATRICS (2007)
Obesity-hypertension: an ongoing pandemic
E. A. Francischetti et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
CD36: Implications in cardiovascular disease
Maria Febbraio et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance
Aase Handberg et al.
CIRCULATION (2006)
Body fat and circulating leukocytes in children
F. Zaldivar et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity
LJ Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort
P Holvoet et al.
DIABETES (2004)
Pathophysiology and biochemistry of cardiovascular disease
J Scott
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance
S Kopprasch et al.
DIABETES (2002)
Interleukin-6 production in human subcutaneous abdominal adipose tissue:: the effect of exercise
D Lyngso et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, ≤30)
IJ Kullo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
A Kaser et al.
BLOOD (2001)
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease
P Holvoet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
S Ehara et al.
CIRCULATION (2001)
Circulating oxidized low density lipoprotein levels - A biochemical risk marker for coronary heart disease
S Toshima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
